UA122336C2 - Бісамідна похідна дикарбонової кислоти як засіб, що стимулює регенерацію тканин і відновлення знижених функцій тканин - Google Patents
Бісамідна похідна дикарбонової кислоти як засіб, що стимулює регенерацію тканин і відновлення знижених функцій тканинInfo
- Publication number
- UA122336C2 UA122336C2 UAA201712838A UAA201712838A UA122336C2 UA 122336 C2 UA122336 C2 UA 122336C2 UA A201712838 A UAA201712838 A UA A201712838A UA A201712838 A UAA201712838 A UA A201712838A UA 122336 C2 UA122336 C2 UA 122336C2
- Authority
- UA
- Ukraine
- Prior art keywords
- agent
- recovery
- dicarboxylic acid
- diminished
- hepatitis
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 4
- 239000002253 acid Substances 0.000 title abstract 2
- 230000003292 diminished effect Effects 0.000 title abstract 2
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical class CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011084 recovery Methods 0.000 title abstract 2
- 230000017423 tissue regeneration Effects 0.000 title abstract 2
- 230000004936 stimulating effect Effects 0.000 title 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 abstract 2
- 208000006454 hepatitis Diseases 0.000 abstract 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 abstract 2
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 2
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 abstract 1
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Винахід належить до галузі медицини і стосується засобу, що стимулює регенерацію тканин і відновлення знижених функцій тканин і органів. Як лікарський засіб для лікування і/або профілактики патологічного стану, вибраного з групи, що включає метаболічний синдром, порушення толерантності до глюкози, гепатит, зокрема хронічний гепатит і токсичний гепатит, ідіопатичний фіброз легені (ІФЛ), емфізему легень, хронічну обструктивну хворобу легень (ХОХЛ), і кахексію, зокрема, обумовлену порушенням толерантності до глюкози, легеневим фіброзом, хронічною обструктивною хворобою легень, раком і іншими захворюваннями. Пропонується застосовувати засіб на основі Треаміду. Останній являє собою бісамідну похідну дикарбонової кислоти формули (I) або її фармацевтично прийнятну сіль. (I)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2015120055A RU2647438C2 (ru) | 2015-05-27 | 2015-05-27 | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
| PCT/RU2016/050015 WO2016190785A1 (ru) | 2015-05-27 | 2016-05-26 | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA122336C2 true UA122336C2 (uk) | 2020-10-26 |
Family
ID=57393489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201712838A UA122336C2 (uk) | 2015-05-27 | 2016-05-26 | Бісамідна похідна дикарбонової кислоти як засіб, що стимулює регенерацію тканин і відновлення знижених функцій тканин |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US10076511B2 (uk) |
| EP (1) | EP3305286A4 (uk) |
| JP (1) | JP6700312B2 (uk) |
| KR (1) | KR102174191B1 (uk) |
| CN (1) | CN108024978B (uk) |
| AU (1) | AU2016266439B2 (uk) |
| BR (1) | BR112017025283A2 (uk) |
| CA (1) | CA2986911C (uk) |
| EA (1) | EA034437B1 (uk) |
| HK (1) | HK1247126A1 (uk) |
| IL (1) | IL255899B (uk) |
| MA (1) | MA45829A (uk) |
| MX (1) | MX2017015192A (uk) |
| RU (2) | RU2647438C2 (uk) |
| SG (1) | SG11201709654YA (uk) |
| UA (1) | UA122336C2 (uk) |
| WO (1) | WO2016190785A1 (uk) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2647438C2 (ru) * | 2015-05-27 | 2018-03-15 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
| CN110087650B (zh) * | 2017-05-26 | 2024-03-22 | 瓦伦塔有限责任公司 | 新的谷氨酰胺酰基环化酶抑制剂及其在治疗多种疾病中的用途 |
| RU2662559C1 (ru) * | 2017-10-27 | 2018-07-26 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый ингибитор глутаминилциклаз и его применение для лечения заболеваний легких и дыхательных путей |
| WO2023177328A1 (en) | 2022-03-17 | 2023-09-21 | Treamid Therapeutics Gmbh | Bisamide derivative of dicarboxylic acid for use in restoring the external respiratory function after coronavirus infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
| RU2647438C2 (ru) * | 2015-05-27 | 2018-03-15 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
| CN110087650B (zh) | 2017-05-26 | 2024-03-22 | 瓦伦塔有限责任公司 | 新的谷氨酰胺酰基环化酶抑制剂及其在治疗多种疾病中的用途 |
-
2015
- 2015-05-27 RU RU2015120055A patent/RU2647438C2/ru active
-
2016
- 2016-05-26 CA CA2986911A patent/CA2986911C/en active Active
- 2016-05-26 AU AU2016266439A patent/AU2016266439B2/en active Active
- 2016-05-26 KR KR1020177037304A patent/KR102174191B1/ko active IP Right Grant
- 2016-05-26 WO PCT/RU2016/050015 patent/WO2016190785A1/ru active Application Filing
- 2016-05-26 EA EA201792565A patent/EA034437B1/ru active IP Right Revival
- 2016-05-26 RU RU2017144851A patent/RU2727142C2/ru active
- 2016-05-26 UA UAA201712838A patent/UA122336C2/uk unknown
- 2016-05-26 SG SG11201709654YA patent/SG11201709654YA/en unknown
- 2016-05-26 BR BR112017025283-0A patent/BR112017025283A2/pt not_active Application Discontinuation
- 2016-05-26 MA MA045829A patent/MA45829A/fr unknown
- 2016-05-26 JP JP2017561321A patent/JP6700312B2/ja active Active
- 2016-05-26 EP EP16800380.4A patent/EP3305286A4/en active Pending
- 2016-05-26 MX MX2017015192A patent/MX2017015192A/es unknown
- 2016-05-26 CN CN201680044227.3A patent/CN108024978B/zh active Active
- 2016-05-26 US US15/576,387 patent/US10076511B2/en active Active
-
2017
- 2017-11-26 IL IL255899A patent/IL255899B/en unknown
-
2018
- 2018-05-25 HK HK18106870.2A patent/HK1247126A1/zh unknown
- 2018-08-14 US US16/103,264 patent/US10772870B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2986911A1 (en) | 2016-12-01 |
| RU2647438C2 (ru) | 2018-03-15 |
| EA201792565A1 (ru) | 2018-04-30 |
| CA2986911C (en) | 2020-06-23 |
| JP6700312B2 (ja) | 2020-05-27 |
| US20180353479A1 (en) | 2018-12-13 |
| WO2016190785A1 (ru) | 2016-12-01 |
| RU2017144851A (ru) | 2019-06-27 |
| HK1247126A1 (zh) | 2018-09-21 |
| KR20180035739A (ko) | 2018-04-06 |
| EP3305286A4 (en) | 2019-06-12 |
| US10076511B2 (en) | 2018-09-18 |
| RU2015120055A (ru) | 2016-12-20 |
| RU2727142C2 (ru) | 2020-07-21 |
| EP3305286A1 (en) | 2018-04-11 |
| RU2017144851A3 (uk) | 2019-07-17 |
| BR112017025283A2 (pt) | 2018-08-07 |
| KR102174191B1 (ko) | 2020-11-05 |
| CN108024978A (zh) | 2018-05-11 |
| IL255899B (en) | 2022-04-01 |
| EA034437B1 (ru) | 2020-02-07 |
| CN108024978B (zh) | 2020-11-20 |
| AU2016266439A1 (en) | 2018-01-25 |
| MX2017015192A (es) | 2018-08-01 |
| SG11201709654YA (en) | 2017-12-28 |
| US20180147184A1 (en) | 2018-05-31 |
| AU2016266439B2 (en) | 2020-05-14 |
| IL255899A (en) | 2018-01-31 |
| MA45829A (fr) | 2019-06-12 |
| US10772870B2 (en) | 2020-09-15 |
| JP2018515584A (ja) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018550148A1 (en) | Hepatitis b antiviral agents | |
| PH12018500088A1 (en) | Substituted tricyclics and method of use | |
| EP4292588A3 (en) | Administration of deuterated cftr potentiators | |
| EA201791780A1 (ru) | Ингаляционный раствор тиотропия для небулайзерного распыления | |
| EA201691375A1 (ru) | (2s)-n-[(1s)-1-циано-2-фенилэтил]-1,4-оксазепан-2-карбоксамиды в качестве ингибиторов дипептидилпептидазы i | |
| PH12020550065A1 (en) | Hepatitis b antiviral agents | |
| JP2015517489A5 (uk) | ||
| MX2017015192A (es) | Derivado de bisamida de acido dicarboxilico como agente que estimula regeneracion de tejidos y recuperacion de funcion tisular disminuida. | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| MX2019012884A (es) | Terapia de combinacion. | |
| BR112014029016A2 (pt) | derivados de ácido 7-oxo-tiazolopiridina carbônico e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| MX2019006938A (es) | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. | |
| EA032951B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
| JP2016510326A5 (uk) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei | |
| JP2015522603A5 (uk) | ||
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| RU2017145271A (ru) | Терапевтическое средство для фиброза | |
| JP2019529569A5 (uk) | ||
| WO2016025671A3 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
| JP2016537344A5 (uk) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. |